Zimmer Recall Labeled High Risk by FDA

Zimmer initiated a recall last month of its PEEK Ardis Inserter instruments for putting too much pressure on its interbody spacers, and the FDA has given it a high-risk Class 1 status.

Advertisement

The device manufacturer received reports of its spacer breaking into fragments because of the Ardis inserter. Such breaks delay surgery and could result in spinal cord tears, cerebrospinal fluid leakage, blood loss or nerve injury.

The PEEK Ardis Implant System will not be available for use or purchase until it is redesigned and cleared by federal regulators.

Class 1 recalls are the most serious type and involve situations that could result in death, according to the FDA.

More Articles on Devices:
Smith & Nephew CFO to Resign
Recall Issued for Medtronic Infusion Pumps
Omeros Shares Drop 9% After Knee Surgery Clinical Trial Results Released

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.